Found 142 results in Expert Content

Summary:​ This insightful webinar explores the latest innovations in pregastric absorption. Learn more about advancements in buccal and sublingual delivery systems, the impact of permeation enhancers, and the role of PBPK modeling in predictive formulation design...

Summary: This executive summary showcases examples of real-life tactical and operational decisions involved in the integrated approach to drug development.

Summary: In this webinar, experts will discuss the advantages of LBFs and softgels while addressing the ongoing challenges in realizing their full clinical and commercial potential.

Summary: This webinar explores formulation and manufacturing strategies, enriched by case studies on lipid-based drug delivery systems and softgels.

Summary: Whether you are looking for accelerated development for your novel therapy, to transform your concepts into differentiated products to grow your brand, or lifecycle management to extend market share and maximize product value, Catalent can be your...

Summary: Zydis ODT offers rapid disintegration, a good mouthfeel and pleasant taste which plays a role in improving patient engagement in their treatment programs and offers an easy-to-take alternative to conventional oral tablets to help meet the needs of specific patient populations such as pediatric, geriatric and dysphagic patients.

This white paper provides valuable insights into the successful application of enteric polymer coatings for controlled drug delivery systems. Discover how this innovative technology can transform your oral drug formulations.

Summary: Zydis® orally disintegrating tablet (ODT) technology creates a unique, freeze-dried oral solid dosage form that disperses almost instantly in the mouth, without water. With more than 35 products launched in 60+ countries, Zydis is the world’s fastest and best-in-class ODT.

Summary: Learn more about orally disintegrating tablets as a solution to various factors that impact treatment adherence rates across various diseases.

An advanced development offering that integrates formulation expertise with on-demand Phase 1 clinical manufacturing, adaptive clinical testing and regulatory support, to help achieve flexible and efficient First-in-Human studies and expedited development.